Works matching DE "BIOSIMILARS"
Results: 899
Pharmacovigilance of biosimilars - Why is it different from generics and innovator biologics?
- Published in:
- Journal of Postgraduate Medicine, 2020, v. 66, n. 2, p. 116, doi. 10.4103/jpgm.JPGM_651_19
- By:
- Publication type:
- Article
Pharmacovigilance of biosimilars – Why is it different from generics and innovator biologics?
- Published in:
- Journal of Postgraduate Medicine, 2019, v. 65, n. 4, p. 227, doi. 10.4103/jpgm.JPGM_109_19
- By:
- Publication type:
- Article
Population pharmacokinetic, pharmacodynamic and efficacy modeling of SB12 (proposed eculizumab biosimilar) and reference eculizumab.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1325, doi. 10.1007/s00228-024-03703-8
- By:
- Publication type:
- Article
Perception of pharmacological equivalence of generics or biosimilars in healthcare professionals in Vienna.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 3, p. 355, doi. 10.1007/s00228-023-03603-3
- By:
- Publication type:
- Article
Uptake of biosimilar trastuzumab in Denmark compared with other European countries: a comparative study and discussion of factors influencing implementation and uptake of biosimilars.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 10, p. 1495, doi. 10.1007/s00228-021-03155-4
- By:
- Publication type:
- Article
Doctor's aptitude for switching from innovator etanercept to biosimilar etanercept in inflammatory rheumatic diseases: experience from a single French rheumatology tertiary care center.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 1, p. 25, doi. 10.1007/s00228-020-02957-2
- By:
- Publication type:
- Article
Clinical evidence supporting the marketing authorization of biosimilars in Europe.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 4, p. 557, doi. 10.1007/s00228-019-02805-y
- By:
- Publication type:
- Article
The Danish model for the quick and safe implementation of infliximab and etanercept biosimilars.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 1, p. 35, doi. 10.1007/s00228-019-02765-3
- By:
- Publication type:
- Article
Regulation of biosimilar medicines and current perspectives on interchangeability and policy.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 1, p. 1, doi. 10.1007/s00228-018-2542-1
- By:
- Publication type:
- Article
Modern therapies in rheumatology: the role of clinical trials.
- Published in:
- Rheumatology Forum, 2023, v. 9, n. 2, p. 81, doi. 10.5603/RF.a2023.0014
- By:
- Publication type:
- Article
Biosimilars in Ophthalmology: Financial Implications and Beyond.
- Published in:
- touchREVIEWS in Ophthalmology, 2022, v. 16, n. 2, p. 98, doi. 10.17925/USOR.2022.16.2.98
- By:
- Publication type:
- Article
Key concepts in biosimilar medicines: What physicians must know.
- Published in:
- Northern Clinics of Istanbul, 2022, v. 9, n. 1, p. 86, doi. 10.14744/nci.2021.84669
- By:
- Publication type:
- Article
Current perspectives on biosimilars.
- Published in:
- Journal of Industrial Microbiology & Biotechnology, 2019, v. 46, n. 9/10, p. 1297, doi. 10.1007/s10295-019-02216-z
- By:
- Publication type:
- Article
Assessment of community pharmacists' knowledge of the differences between generic drugs and biosimilars: A pilot cross-sectional study.
- Published in:
- Medicine Access @ Point of Care, 2023, v. 7, p. 1, doi. 10.1177/27550834231167049
- By:
- Publication type:
- Article
Availability and accessibility of monoclonal antibodies in Bosnia and Herzegovina: Findings and implications.
- Published in:
- Medicine Access @ Point of Care, 2021, p. 1, doi. 10.1177/23992026211027692
- By:
- Publication type:
- Article
Real-World Study of Adjuvant Biosimilar Trastuzumab-dkst for HER2-Positive Breast Cancer Treatment in a Brazilian Population.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 437, doi. 10.1007/s40487-024-00284-5
- By:
- Publication type:
- Article
Long-Term Safety and Effectiveness of Rituximab Biosimilar RTXM83: A Retrospective Extension Study in Brazilian Patients with Diffuse Large B-Cell Lymphoma.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 585, doi. 10.1007/s40487-024-00282-7
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, Tolerability, and Immunogenicity of BP02 (Trastuzumab Biosimilar) Compared to EU- and US-Approved Trastuzumab in Healthy Adult Male Volunteers: A Phase 1, Randomized, Double-Blind Study.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 477, doi. 10.1007/s40487-024-00289-0
- By:
- Publication type:
- Article
Patent Claim Scope and Biosimilar Competition in the US and EU.
- Published in:
- Journal of Law, Medicine & Ethics, 2024, v. 52, n. 2, p. 439, doi. 10.1017/jme.2024.133
- By:
- Publication type:
- Article
USPTO's Lax Policy Leads to Humira Formulation Thicket.
- Published in:
- Journal of Law, Medicine & Ethics, 2024, v. 52, n. 2, p. 429, doi. 10.1017/jme.2024.132
- By:
- Publication type:
- Article
INTRODUCTION: Rethinking Pharmaceutical Policies in Latin America and the Caribbean: An Overview.
- Published in:
- Journal of Law, Medicine & Ethics, 2023, v. 51, p. 6, doi. 10.1017/jme.2023.135
- By:
- Publication type:
- Article
Biosimilars and Heterogeneous Technological Trajectories in the Argentine Biopharmaceutical Industry.
- Published in:
- Journal of Law, Medicine & Ethics, 2023, v. 51, p. 116, doi. 10.1017/jme.2023.134
- By:
- Publication type:
- Article
From Pharmaceutical Innovation to Revenue Generation: The Asian Experience.
- Published in:
- Journal of Law, Medicine & Ethics, 2023, v. 51, p. 62, doi. 10.1017/jme.2023.121
- By:
- Publication type:
- Article
Pharmaceutical Innovation in Latin America and the Caribbean.
- Published in:
- Journal of Law, Medicine & Ethics, 2023, v. 51, p. 148, doi. 10.1017/jme.2023.120
- By:
- Publication type:
- Article
Knowledge, Perceptions, and Utilization of Generics and Biosimilars in Latin America and the Caribbean: A Scoping Review.
- Published in:
- Journal of Law, Medicine & Ethics, 2023, v. 51, p. 100, doi. 10.1017/jme.2023.117
- By:
- Publication type:
- Article
The Pharmaceutical Market for Biological Products in Latin America: A Comprehensive Analysis of Regional Sales Data.
- Published in:
- Journal of Law, Medicine & Ethics, 2023, v. 51, p. 39, doi. 10.1017/jme.2023.112
- By:
- Publication type:
- Article
How to Price and to Reimburse Publicly Funded Medicines in Latin America? Lessons Learned from Europe.
- Published in:
- Journal of Law, Medicine & Ethics, 2023, v. 51, p. 76, doi. 10.1017/jme.2023.114
- By:
- Publication type:
- Article
Promoting Competition in Drug Pricing: A Review of Recent Congressional Legislation.
- Published in:
- Journal of Law, Medicine & Ethics, 2021, v. 49, n. 4, p. 683, doi. 10.1017/jme.2021.93
- By:
- Publication type:
- Article
The Disappointment of the Biosimilar.
- Published in:
- Journal of Law, Medicine & Ethics, 2018, v. 46, n. 3, p. 791, doi. 10.1177/1073110518804242
- By:
- Publication type:
- Article
Similar or the Same? Why Biosimilars are not the Solution.
- Published in:
- Journal of Law, Medicine & Ethics, 2018, v. 46, n. 3, p. 776, doi. 10.1177/1073110518804241
- By:
- Publication type:
- Article
Indian Biosimilars and Vaccines at Crossroads–Replicating the Success of Pharmagenerics.
- Published in:
- Vaccines, 2023, v. 11, n. 1, p. 110, doi. 10.3390/vaccines11010110
- By:
- Publication type:
- Article
Relationship between injection site reactions and different adalimumab formulations. Analysis of the adverse events reported in Italy in 2016-2019.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2021, v. 25, n. 8, p. 3300
- By:
- Publication type:
- Article
Similarity assessment by multivariate statistics method based on the distance between biosimilar and originator.
- Published in:
- Bioresources & Bioprocessing, 2021, v. 8, n. 1, p. 1, doi. 10.1186/s40643-021-00378-2
- By:
- Publication type:
- Article
Management of the National Drug Administration Through the Use of Biosimilar Medicines. Expenditures, Numbers of Reimbursed Packages and Shares of Biosimilar Products in the Infliximab Market a Year Prior to and a Year after the Introduction of the National Drug Policy 2018-2022.
- Published in:
- Management Issues / Problemy Zarządzania, 2020, v. 18, n. 3, p. 121, doi. 10.7172/1644-9584.89.7
- By:
- Publication type:
- Article
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/9996193
- By:
- Publication type:
- Article
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/9996193
- By:
- Publication type:
- Article
Parallelism of Chemicostructural Properties between Filgrastim Originator and Three of Its Biosimilar Drugs.
- Published in:
- Journal of Chemistry, 2019, p. 1, doi. 10.1155/2019/2751461
- By:
- Publication type:
- Article
Panel: Biosimilar Adoption Dependent on Various Stakeholder Economics.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 1, p. 9
- Publication type:
- Article
Update on Oncology Biosimilars in 2020.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2020, v. 11, n. 8, p. 283
- Publication type:
- Article
Efficacy and safety of MYL‐1501D versus insulin glargine in patients with type 2 diabetes after 24 weeks: Results of the phase III INSTRIDE 2 study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 129, doi. 10.1111/dom.13495
- By:
- Publication type:
- Article
Efficacy and safety of MYL‐1501D vs insulin glargine in patients with type 1 diabetes after 52 weeks: Results of the INSTRIDE 1 phase III study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1944, doi. 10.1111/dom.13322
- By:
- Publication type:
- Article
Biosimilars.
- Published in:
- Lupus, 2020, v. 29, n. 6, p. 525, doi. 10.1177/0961203320910797
- By:
- Publication type:
- Article
Biosimilars provide an opportunity to lower the cost of treatment with bDMARDs - Prof. Tore K. Kvien.
- Published in:
- Pulse International, 2019, v. 20, n. 9, p. N.PAG
- Publication type:
- Article
Without understanding Biologics, Biosimilars, Bioavailability and Bioequivalence, we can't proceed further - Prof. Herzig.
- Published in:
- Pulse International, 2018, v. 19, n. 10, p. 4
- Publication type:
- Article
Gaziantep Üniversitesi Tıp Fakültesi Şahinbey Araştırma Ve Uygulama Hastanesi'nde Yatan Hastaların Akılcı İlaç Kullanımı İle İlgili Davranışlarının Değerlendirilmesi.
- Published in:
- Journal of Harran University Medical Faculty / Harran Üniversitesi Tıp Fakültesi Dergisi, 2015, v. 12, n. 2, p. 240
- By:
- Publication type:
- Article
Home administration of filgrastim (Nivestim™) in primary prophylaxis of chemotherapy-induced febrile neutropenia.
- Published in:
- Patient Preference & Adherence, 2018, v. 12, p. 2179, doi. 10.2147/PPA.S168029
- By:
- Publication type:
- Article
Biosimilars for Rheumatoid Arthritis: Riding the 2023 Wave [Podcast].
- Published in:
- Open Access Rheumatology: Research & Reviews, 2023, v. 15, p. 207, doi. 10.2147/OARRR.S443235
- By:
- Publication type:
- Article
A cost-effectiveness evaluation of the originator follitropin alpha compared to the biosimilars for assisted reproduction in Germany.
- Published in:
- International Journal of Women's Health, 2019, v. 11, p. 319, doi. 10.2147/IJWH.S193048
- By:
- Publication type:
- Article
Epoetin alfa-epbx: a new entrant into a crowded market. a historical review of the role of erythropoietin stimulating agents and the development of the first epoetin biosimilar in the United States.
- Published in:
- Expert Review of Clinical Pharmacology, 2021, v. 14, n. 1, p. 1, doi. 10.1080/17512433.2021.1863786
- By:
- Publication type:
- Article
Survey of Data Package and Sample Size of Comparative Clinical Studies for Biosimilar Developments from PMDA Assessments.
- Published in:
- Pharmaceutical Medicine, 2024, v. 38, n. 3, p. 225, doi. 10.1007/s40290-024-00525-y
- By:
- Publication type:
- Article